• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Debating Weight Loss vs. Weight Neutral Strategies for Improvements of Health.探讨减肥与体重中性策略对健康改善的影响。
Curr Obes Rep. 2024 Dec;13(4):832-842. doi: 10.1007/s13679-024-00587-8. Epub 2024 Sep 17.
2
Are Current Guidelines Perpetuating Weight Stigma? A Weight-Skeptical Approach to the Care of Patients with Obesity.现行指南是否在加剧体重歧视?对肥胖患者护理的持怀疑态度的体重观点。
J Gen Intern Med. 2023 Feb;38(3):793-798. doi: 10.1007/s11606-022-07821-w. Epub 2022 Sep 22.
3
Weight loss interventions for chronic asthma.慢性哮喘的体重减轻干预措施。
Cochrane Database Syst Rev. 2012 Jul 11;2012(7):CD009339. doi: 10.1002/14651858.CD009339.pub2.
4
The effect of weight management interventions that include a diet component on weight-related outcomes in pregnant and postpartum women: a systematic review protocol.包含饮食成分的体重管理干预措施对孕妇和产后女性体重相关结局的影响:一项系统评价方案
JBI Database System Rev Implement Rep. 2015 Jan;13(1):88-98. doi: 10.11124/jbisrir-2015-1812.
5
6
Weight Loss and the Prevention and Treatment of Type 2 Diabetes Using Lifestyle Therapy, Pharmacotherapy, and Bariatric Surgery: Mechanisms of Action.体重减轻与生活方式治疗、药物治疗和减重手术预防和治疗 2 型糖尿病:作用机制。
Curr Obes Rep. 2015 Jun;4(2):287-302. doi: 10.1007/s13679-015-0155-x.
7
Long-term drug treatment for obesity: a systematic and clinical review.长期药物治疗肥胖:系统评价和临床综述。
JAMA. 2014 Jan 1;311(1):74-86. doi: 10.1001/jama.2013.281361.
8
Treatment modalities of obesity: what fits whom?肥胖的治疗方式:哪种适合谁?
Diabetes Care. 2008 Feb;31 Suppl 2:S269-77. doi: 10.2337/dc08-s265.
9
Intensive lifestyle intervention combined with the choice of pharmacotherapy improves weight loss and cardiac risk factors in the obese.强化生活方式干预结合药物治疗选择可改善肥胖者的体重减轻及心脏危险因素。
J Hum Nutr Diet. 2002 Aug;15(4):287-95; quiz 297-9. doi: 10.1046/j.1365-277x.2002.00373.x.
10
The future of Cochrane Neonatal.考克兰新生儿协作网的未来。
Early Hum Dev. 2020 Nov;150:105191. doi: 10.1016/j.earlhumdev.2020.105191. Epub 2020 Sep 12.

引用本文的文献

1
Weight Stigma in the Metabolic Bariatric Surgery Context: Current State of the Literature, Conceptual Model, and Looking Forward.代谢减重手术背景下的体重歧视:文献现状、概念模型及展望
Curr Obes Rep. 2025 Jul 16;14(1):59. doi: 10.1007/s13679-025-00651-x.
2
The Impact of Novel Medications for Obesity on Weight Stigma and Societal Attitudes: A Narrative Review.新型肥胖药物对体重歧视和社会态度的影响:一项叙述性综述。
Curr Obes Rep. 2025 Feb 5;14(1):18. doi: 10.1007/s13679-025-00611-5.

本文引用的文献

1
Early findings from the NHS Type 2 Diabetes Path to Remission Programme: a prospective evaluation of real-world implementation.NHS 2 型糖尿病缓解计划的早期发现:真实世界实施情况的前瞻性评估。
Lancet Diabetes Endocrinol. 2024 Sep;12(9):653-663. doi: 10.1016/S2213-8587(24)00194-3. Epub 2024 Aug 5.
2
An Overview of Research on Acceptance and Commitment Therapy.接纳与承诺疗法研究概述。
Psychiatr Clin North Am. 2024 Jun;47(2):419-431. doi: 10.1016/j.psc.2024.02.007. Epub 2024 Mar 21.
3
5-year follow-up of the randomised Diabetes Remission Clinical Trial (DiRECT) of continued support for weight loss maintenance in the UK: an extension study.英国减肥维持持续支持随机糖尿病缓解临床试验(DiRECT)的 5 年随访:一项扩展研究。
Lancet Diabetes Endocrinol. 2024 Apr;12(4):233-246. doi: 10.1016/S2213-8587(23)00385-6. Epub 2024 Feb 26.
4
The Physiological Effects of Weight-Cycling: A Review of Current Evidence.体重波动的生理效应:当前证据综述。
Curr Obes Rep. 2024 Mar;13(1):35-50. doi: 10.1007/s13679-023-00539-8. Epub 2024 Jan 3.
5
More questions than answers.问题多于答案。
Science. 2023 Dec 15;382(6676):1213. doi: 10.1126/science.adn3693. Epub 2023 Dec 14.
6
Semaglutide and Cardiovascular Outcomes in Obesity without Diabetes.司美格鲁肽在肥胖但无糖尿病患者中的心血管结局。
N Engl J Med. 2023 Dec 14;389(24):2221-2232. doi: 10.1056/NEJMoa2307563. Epub 2023 Nov 11.
7
Bariatric surgery and obstructive sleep apnea: a systematic review and meta-analysis.减重手术与阻塞性睡眠呼吸暂停:系统评价与荟萃分析。
Sleep Breath. 2023 Dec;27(6):2283-2294. doi: 10.1007/s11325-023-02840-1. Epub 2023 May 5.
8
"I'll never sacrifice my well-being again:" The journey from negative to positive body image among women who perceive their body to deviate from societal norms.“我再也不会牺牲自己的幸福了”:那些认为自己的身体偏离社会规范的女性从负面身体形象转变为正面身体形象的历程。
Body Image. 2023 Jun;45:153-171. doi: 10.1016/j.bodyim.2023.03.001. Epub 2023 Mar 17.
9
Comparative effectiveness of glucagon-like peptide-1 receptor agonists for the management of obesity in adults without diabetes: A network meta-analysis of randomized clinical trials.胰高血糖素样肽-1受体激动剂治疗非糖尿病成年肥胖患者的比较效果:一项随机临床试验的网状荟萃分析
Obes Rev. 2023 Mar;24(3):e13543. doi: 10.1111/obr.13543. Epub 2022 Dec 29.
10
Once-Weekly Semaglutide in Adolescents with Obesity.每周一次司美格鲁肽治疗肥胖青少年。
N Engl J Med. 2022 Dec 15;387(24):2245-2257. doi: 10.1056/NEJMoa2208601. Epub 2022 Nov 2.

探讨减肥与体重中性策略对健康改善的影响。

Debating Weight Loss vs. Weight Neutral Strategies for Improvements of Health.

机构信息

Research Unit for Dietary Studies at The Parker Institute, Bispebjerg and Frederiksberg Hospital, Part of the Copenhagen University Hospital, Frederiksberg, 2000, Denmark.

The Boden Initiative, The Charles Perkins Centre, The University of Sydney, Sydney, NSW, 2006, Australia.

出版信息

Curr Obes Rep. 2024 Dec;13(4):832-842. doi: 10.1007/s13679-024-00587-8. Epub 2024 Sep 17.

DOI:10.1007/s13679-024-00587-8
PMID:39289256
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11522117/
Abstract

PURPOSE OF REVIEW

Despite decades of development and testing of weight-loss interventions, the adult populations worldwide have witnessed a continuous rise in body weight. There is an ongoing debate about how to move forward. Some argue that this rise calls for more intensive and possibly life-long treatments, including the new effective GLP1 weight loss medications, while others have called for a fundamental shift away from weight and on to a broader understanding of health. The two strategies are represented as a weight-centric health strategy and a weight neutral health strategy. This paper debates the benefits and potential harms related to the use of these two strategies.

RECENT FINDINGS

While major weight loss may have substantial health benefits, many individuals will need intensive treatment including weight loss medication to achieve it, as generally few are able to sustain a lifestyle induced weight loss in the long term. Both the weight loss and the weight-neutral health strategies have advantages and limitations emphasizing the need for further research comparing the two strategies. Currently, not everyone is offered, can afford, will tolerate or even desire treatment with weight loss medication, and weight neutral health strategies may be a desirable alternative intervention offering a more holistic approach to health and addressing psychological and social issues including the burden of experienced and internalized weight stigma. However, this method still needs to be tested for effectiveness with regards to both physical and long-term psychological benefits.

摘要

目的综述:尽管几十年来不断开发和测试减肥干预措施,但全球成年人口的体重仍持续上升。关于如何继续前进,目前存在争议。一些人认为,这种上升需要更密集和可能终生的治疗,包括新的有效的 GLP1 减肥药,而另一些人则呼吁从体重上彻底转变,转而更广泛地理解健康。这两种策略被表示为以体重为中心的健康策略和体重中立的健康策略。本文讨论了使用这两种策略的相关益处和潜在危害。

最近发现:虽然体重显著减轻可能会带来重大的健康益处,但许多人需要进行强化治疗,包括使用减肥药,才能实现这一目标,因为一般来说,很少有人能够长期维持生活方式引起的体重减轻。减肥和体重中立的健康策略都有其优点和局限性,强调需要进一步研究比较这两种策略。目前,并非每个人都能得到、负担得起、愿意或甚至渴望接受减肥药治疗,而体重中立的健康策略可能是一种理想的替代干预措施,提供更全面的健康方法,并解决心理和社会问题,包括所经历和内化的体重耻辱感的负担。然而,这种方法仍需要在身体和长期心理益处方面进行有效性测试。